» Articles » PMID: 37779511

When There is No Guidance From the Guidelines: Renal Transplantation in Recipients With Class III Obesity

Overview
Journal Transpl Int
Specialty General Surgery
Date 2023 Oct 2
PMID 37779511
Authors
Affiliations
Soon will be listed here.
Abstract

Whilst renal transplantation is the optimal treatment for many patients with end-stage kidney disease, the latest international guidelines are unable to make recommendations for the management of patients with end-stage kidney stage kidney disease and Class III Obesity (BMI ≥40 kg/m). Data on all adult patients receiving a kidney-only-transplant in the UK between 2015-2021 were analysed from a prospectively collected database and interrogated across a range of parameters. We then analysed in detail the outcomes of patients transplanted at the highest-volume unit. There were 22,845 renal transplants in the study time-period; just 44 (0.2%) were performed in recipients with a BMI ≥40 kg/m. Most transplant centres did not transplant any patients in this category. In the centre with the highest volume, there were 21 transplants (9 living donor) performed in 20 individuals (13 male, median age 46 years). One-year patient and death-censored graft survival was 95% and 85%. Successful transplantation is possible in patients with BMI ≥40 kg/m but carries additional risk. Obesity should not be the sole factor considered when deciding on transplant suitability. Restricting transplantation to a small number of high-volume centres in each country should be considered to optimize outcomes.

References
1.
Scheuermann U, Babel J, Pietsch U, Weimann A, Lyros O, Semmling K . Recipient obesity as a risk factor in kidney transplantation. BMC Nephrol. 2022; 23(1):37. PMC: 8767742. DOI: 10.1186/s12882-022-02668-z. View

2.
Meier-Kriesche H, Kaplan B . Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation. 2002; 74(10):1377-81. DOI: 10.1097/00007890-200211270-00005. View

3.
Ri M, Aikou S, Seto Y . Obesity as a surgical risk factor. Ann Gastroenterol Surg. 2018; 2(1):13-21. PMC: 5881295. DOI: 10.1002/ags3.12049. View

4.
Harhay M, Ranganna K, Boyle S, Brown A, Bajakian T, Levin Mizrahi L . Association Between Weight Loss Before Deceased Donor Kidney Transplantation and Posttransplantation Outcomes. Am J Kidney Dis. 2019; 74(3):361-372. PMC: 6708783. DOI: 10.1053/j.ajkd.2019.03.418. View

5.
Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M . A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015; 373(1):11-22. DOI: 10.1056/NEJMoa1411892. View